Background: Replacing SFAs with vegetable PUFAs has cardiometabolic benefits, but the
effects on liver fat are unknown. Increased dietary n-6 PUFAs have, however, also been …

Background: Chronic adipose tissue inflammation is a hallmark of obesity, triggering the
development of associated pathologies, particularly type 2 diabetes. Long-chain n− 3 …

Background: Postprandial dyslipidaemia occurs in obesity and insulin resistance (IR), and is
associated with an increased risk of developing cardiovascular disease. We have recently …

Background Dietary intake of n-3 polyunsaturated fatty acids (PUFA) is primarily recognized
to protect against cardiovascular diseases, cognitive dysfunctions and the onset of obesity …

Scope Dietary n‐3 long‐chain PUFAs (n‐3 LCPUFAs) supplementation was studied in an
HFD‐induced (HFD is high‐fat diet) steatosis and inflammation in relation to peroxisome …

Obesity is associated with elevated levels of inflammation and metabolic abnormalities
which are linked to CVD. The aim of the present study was to investigate whether long-chain …

BACKGROUND: Obesity is associated with elevated levels of inflammation and metabolic
abnormalities, with increased risk of developing insulin resistance, type 2 diabetes, stroke …

Obesity is a growing problem that threatens the health and welfare of a large proportion of
the human population. The n-3 polyunsaturated fatty acids (PUFA) are dietary factors that …

Adipose tissue has a key role in the development of metabolic syndrome (MS), which
includes obesity, type 2 diabetes, dyslipidaemia, hypertension and other disorders. Systemic …

Strategies to reduce obesity have become public health priorities as the prevalence of
obesity has risen in the United States and around the world. While the anti-inflammatory and …